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4. Colita refers to single dose nevirapine prior to delivery, followed by a tail of triple therapy for seven days after delivery.
5. These 3 patients are women who presented to the Altagracia prior to delivery and were started on HAART at that time, 
or women who received prenatal care including HAART at an outside institution.
Methods
.
The impact of HIV infection 
on maternal and infant 
mortality in the Dominican 
Republic is unknown.  The 
prevalence of HIV infection 
among pregnant women in 
the Dominican Republic is 1-
2%, and over two-thirds of 
women receive prenatal care 
(1,2).  It is estimated that 
15% of all deliveries in the 
Dominican Republic occur at 
the Hospital Maternidad 
Nuestra Señora de la 
Altagracia in Santo 
Domingo, making this the 
highest-volume maternity 
hospital in the country (3). 
We conducted a study 
to compare the impact 
of HIV infection on 
pregnant women 
receiving prenatal care 
including highly active 
antiretroviral therapy 
(HAART) versus 
women who were not 
identified as HIV 
positive until the time 
of delivery.  All 
research took place at 
the Hospital 
Maternidad Nuestra 
Señora de la Altagracia 
(Altagracia), Santo 
Domingo, DR.  
We performed a retrospective chart review at the Office 
of Reduction of Vertical Transmission of HIV at the 
Altagracia.  All deliveries May-September, 2009, were 
included.  Data were compared to a record book listing 
monthly deliveries of HIV infected women.  
Data points included: patient age at time of presentation 
to the PMTCT clinic or at the time of initial presentation 
for delivery; gestational age at time of presentation; 
gestational age at start of HAART; mode of delivery; 
whether a woman was less than 20 years old at time of 
presentation; whether she gave birth to a living child; 
and treatment the child received after delivery. 
All data were collected in a de-identified manner by 
Ingrid Liff, a senior medical student at the University of 
Massachusetts Medical School.  This study was 
approved by the IRB at the University of Massachusetts.     
(IRB Exempt status #13713).
Between May and September, 2009, we identified 91 HIV positive women 
who delivered at the Altagracia.  Forty-nine women (54%) received prenatal 
care through the Office for Reduction of Vertical Transmission of HIV.  All of 
these 49 women received HAART prior to delivery.  Of these 49 women, 80% 
underwent Cesarean delivery, and 12% were adolescents (<20 years old).  
There was no infant mortality in this group (Figure 1).
Forty-two women (46%) were identified as HIV infected at the time of labor, 
and only 7% of these women received HAART prior to delivery.  Sixty-two 
percent of these women received no treatment for HIV infection prior to 
delivery.  Seven percent received single dose nevirapine and 14% received 
Colita (4). Of these 42 women, 48% underwent Cesarean delivery, 21% were 
adolescents (<20 years old), and there were 2 infant deaths (Figure 2).
According to data collected at the time of delivery, all living newborns 
delivered to the HIV positive mothers in our study received treatment with a 
6-week course of zidovudine (AZT) per national protocol.  All of the 
newborns also received formula at the time of delivery and were not 
breastfed.      
This observational study emphasizes the need for a more aggressive approach to identify HIV infected 
pregnant women prior to labor.  In this cohort, all HIV positive pregnant women who received prenatal care 
at the PMTCT clinic received HAART prior to delivery, as opposed to those who were identified during 
labor.
Until recently, newborns born at the Altagracia were lost to follow-up.  At this time there is no data on 
whether the infants in this study population are HIV positive.  Further research is warranted to uncover the 
rate of vertical transmission at the Hospital Maternidad Nuestra Señora de la Altagracia in Santo Domingo. 
Patients who received prenatal care through the Program for Reduction of Vertical 
Transmission of HIV at the Hospital Maternidad Nuestra Señora de la Altagracia
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